BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15332330)

  • 1. Multivariate analysis of clinical prognostic factors in children with intracranial ependymomas.
    Jaing TH; Wang HS; Tsay PK; Tseng CK; Jung SM; Lin KL; Lui TN
    J Neurooncol; 2004 Jul; 68(3):255-61. PubMed ID: 15332330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supratentorial extraventricular ependymomas: A retrospective study focused on long-term outcomes and prognostic factors.
    Wang M; Zhang R; Liu X; Li D; Qiu C; Zhao P; Zuo Y; Zhang P; Wang J; Sun H
    Clin Neurol Neurosurg; 2018 Feb; 165():1-6. PubMed ID: 29253745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic factors and results after the combined surgical and radiotherapy treatment of ependymomas].
    Grabenbauer GG; Barta B; Erhardt J; Buchfelder M; Thierauf P; Beck JD; Sauer R
    Strahlenther Onkol; 1992 Dec; 168(12):679-85. PubMed ID: 1481116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ependymoma: results, prognostic factors and treatment recommendations.
    McLaughlin MP; Marcus RB; Buatti JM; McCollough WM; Mickle JP; Kedar A; Maria BL; Million RR
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):845-50. PubMed ID: 9531369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas.
    Cage TA; Clark AJ; Aranda D; Gupta N; Sun PP; Parsa AT; Auguste KI
    J Neurosurg Pediatr; 2013 Jun; 11(6):673-81. PubMed ID: 23540528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and survival of supratentorial and posterior fossa ependymomas in adults.
    Nuño M; Yu JJ; Varshneya K; Alexander J; Mukherjee D; Black KL; Patil CG
    J Clin Neurosci; 2016 Jun; 28():24-30. PubMed ID: 26810473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracranial ependymomas in childhood: a report of 24 cases followed for 5 years.
    Jayawickreme DP; Hayward RD; Harkness WF
    Childs Nerv Syst; 1995 Jul; 11(7):409-13. PubMed ID: 7585670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors.
    Hollon T; Nguyen V; Smith BW; Lewis S; Junck L; Orringer DA
    J Neurosurg; 2016 Aug; 125(2):410-8. PubMed ID: 26745489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primitive intracranial ependymomas. Salah-Azaîz institute experience.
    Ben Ammar CN; Kochbati L; Frikha H; Gargouri W; Benna F; Besbes M; Ben Abdallah M; Ben Attia R; Maalej M
    Cancer Radiother; 2004 Apr; 8(2):75-80. PubMed ID: 15063874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome in patients harboring intracranial ependymoma.
    Kawabata Y; Takahashi JA; Arakawa Y; Hashimoto N
    J Neurosurg; 2005 Jul; 103(1):31-7. PubMed ID: 16121970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors and treatment options for paediatric ependymomas.
    Vaidya K; Smee R; Williams JR
    J Clin Neurosci; 2012 Sep; 19(9):1228-35. PubMed ID: 22840355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical management of supratentorial ependymomas.
    Chakraborty A; Harkness W; Phipps K
    Childs Nerv Syst; 2009 Oct; 25(10):1215-20. PubMed ID: 19357853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both location and age predict survival in ependymoma: a SEER study.
    McGuire CS; Sainani KL; Fisher PG
    Pediatr Blood Cancer; 2009 Jan; 52(1):65-9. PubMed ID: 19006249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of copy number variants in the classification of intracranial ependymoma.
    Evenson M; Cai C; Hucthagowder V; McNulty S; Neidich J; Kulkarni S; Dahiya S
    Cancer Genet; 2020 Jan; 240():66-72. PubMed ID: 31794935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric infratentorial ependymoma: prognostic significance of anaplastic histology.
    Phi JH; Wang KC; Park SH; Kim IH; Kim IO; Park KD; Ahn HS; Lee JY; Son YJ; Kim SK
    J Neurooncol; 2012 Feb; 106(3):619-26. PubMed ID: 21863401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic results of eight patients with intracranial ependymomas].
    Sasajima T; Takahashi M; Kinouchi H; Suzuki A; Mizoi K
    No To Shinkei; 2003 Mar; 55(3):233-40. PubMed ID: 12728504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative radiotherapy of spinal and intracranial ependymomas: analysis of prognostic factors.
    Stüben G; Stuschke M; Kroll M; Havers W; Sack H
    Radiother Oncol; 1997 Oct; 45(1):3-10. PubMed ID: 9364625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history and role of radiation in patients with supratentorial and infratentorial WHO grade II ependymomas: results from a population-based study.
    Aizer AA; Ancukiewicz M; Nguyen PL; Macdonald SM; Yock TI; Tarbell NJ; Shih HA; Loeffler JS; Oh KS
    J Neurooncol; 2013 Dec; 115(3):411-9. PubMed ID: 24057324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of chromosome 1q gain in intracranial ependymomas.
    Rajeshwari M; Sharma MC; Kakkar A; Nambirajan A; Suri V; Sarkar C; Singh M; Saran RK; Gupta RK
    J Neurooncol; 2016 Apr; 127(2):271-8. PubMed ID: 26725097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative radiotherapy for intracranial ependymoma: analysis of prognostic factors and patterns of failure.
    Oya N; Shibamoto Y; Nagata Y; Negoro Y; Hiraoka M
    J Neurooncol; 2002 Jan; 56(1):87-94. PubMed ID: 11949831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.